SI2291369T1 - Benzodioksinil substituirani derivati indazola - Google Patents

Benzodioksinil substituirani derivati indazola

Info

Publication number: SI2291369T1
Authority: SI; Slovenia
Prior art keywords: indazole derivatives; substituted indazole; benzodioxinyl; benzodioxinyl substituted; derivatives
Prior art date: 2008-05-20

Application number

SI200931365T

Other languages

English (en)

Inventor

Markus Berger

Jan Dahmen

Karl Edman

Anders Eriksson

Thomas Hansson

Martin Hemmerling

Nafizal Hossain

Per Thomas Klingstedt

Matti Lepisto

Stinabritt Nilsson

Hartmut Rehwinkel

Original Assignee

Astrazeneca Ab

Bayer Pharma Aktiengesellschaft

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-05-20

Filing date

2009-05-20

Publication date

2016-02-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41340347&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2291369(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-05-20 Application filed by Astrazeneca Ab, Bayer Pharma Aktiengesellschaft filed Critical Astrazeneca Ab

2016-02-29 Publication of SI2291369T1 publication Critical patent/SI2291369T1/sl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Neurology (AREA)
Immunology (AREA)
Pulmonology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Cardiology (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Heart & Thoracic Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Otolaryngology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Ophthalmology & Optometry (AREA)
Vascular Medicine (AREA)
Transplantation (AREA)

SI200931365T 2008-05-20 2009-05-20 Benzodioksinil substituirani derivati indazola SI2291369T1 (sl)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US5461608P	2008-05-20	2008-05-20
US8031208P	2008-07-14	2008-07-14
US14477609P	2009-01-15	2009-01-15
EP09750866.7A EP2291369B1 (en)	2008-05-20	2009-05-20	Benzodioxinyl substituted indazole derivatives
PCT/SE2009/000267 WO2009142571A1 (en)	2008-05-20	2009-05-20	Phenyl and benzodioxinyl substituted indazoles derivatives

Publications (1)

Publication Number	Publication Date
SI2291369T1 true SI2291369T1 (sl)	2016-02-29

Family

ID=41340347

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200931365T SI2291369T1 (sl)	2008-05-20	2009-05-20	Benzodioksinil substituirani derivati indazola

Country Status (42)

Country	Link
US (5)	US8211930B2 (sl)
EP (3)	EP2291359A4 (sl)
JP (3)	JP2011520954A (sl)
KR (2)	KR101593253B1 (sl)
CN (2)	CN102112449A (sl)
AR (2)	AR071857A1 (sl)
AU (2)	AU2009249872A1 (sl)
BR (2)	BRPI0912878B1 (sl)
CA (2)	CA2724508C (sl)
CL (2)	CL2009001248A1 (sl)
CO (2)	CO6331310A2 (sl)
CR (2)	CR11801A (sl)
CY (1)	CY1117330T1 (sl)
DK (1)	DK2291369T3 (sl)
DO (2)	DOP2010000359A (sl)
EA (2)	EA018629B8 (sl)
EC (2)	ECSP10010620A (sl)
ES (1)	ES2561598T3 (sl)
HK (1)	HK1154580A1 (sl)
HN (1)	HN2010002478A (sl)
HR (1)	HRP20160071T1 (sl)
HU (1)	HUE027217T2 (sl)
IL (2)	IL209122A0 (sl)
MA (2)	MA32383B1 (sl)
ME (1)	ME02455B (sl)
MX (2)	MX2010012529A (sl)
MY (1)	MY173448A (sl)
NI (1)	NI201000199A (sl)
NZ (1)	NZ588994A (sl)
PA (2)	PA8827001A1 (sl)
PE (2)	PE20091925A1 (sl)
PL (1)	PL2291369T3 (sl)
PT (1)	PT2291369E (sl)
RS (1)	RS54700B1 (sl)
SA (1)	SA109300309B1 (sl)
SI (1)	SI2291369T1 (sl)
SV (2)	SV2010003737A (sl)
TW (2)	TWI445705B (sl)
UA (1)	UA102543C2 (sl)
UY (2)	UY31831A (sl)
WO (2)	WO2009142571A1 (sl)
ZA (2)	ZA201007919B (sl)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JO2754B1 (en) *	2006-12-21	2014-03-15	استرازينكا ايه بي	Amylendazoleil derivatives for the treatment of glucocorticoid-mediated disorders
AU2009228398B2 (en)	2008-03-24	2014-07-03	Medivation Technologies, Inc.	Pyrido [3, 4-b] indoles and methods of use
SA109300309B1 (ar) *	2008-05-20	2013-01-22	باير شيرنج فارما ايه جي	مشتقات فينيل وبنزو داي أوكسينيل إندازول بها استبدال
JP2012525353A (ja)	2009-04-30	2012-10-22	ビーエーエスエフソシエタス・ヨーロピア	置換型イソオキサゾリン化合物およびその前駆体の調製方法
WO2011061527A1 (en) *	2009-11-17	2011-05-26	Astrazeneca Ab	Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
FR2955105B1 (fr)	2010-01-11	2012-04-20	Arkema France	Procede de preparation d'aminoethyl imidazolidone ou de son thiocarbonyle
EP2585443B1 (en)	2010-06-23	2015-02-18	Basf Se	Process for producing imine compounds for combating invertebrate pests
US9006447B2 (en)	2010-11-03	2015-04-14	Basf Se	Method for preparing substituted isoxazoline compounds and their precursors 4-chloro, 4-bromo- or 4-iodobenzaldehyde oximes
GB201021979D0 (en)	2010-12-23	2011-02-02	Astrazeneca Ab	New compound
GB201021992D0 (en)	2010-12-23	2011-02-02	Astrazeneca Ab	Compound
CN103476417A (zh)	2011-02-18	2013-12-25	梅迪维新技术公司	治疗糖尿病的化合物和方法
US9974759B2 (en)	2013-05-31	2018-05-22	Indiana University Research And Technology Corporation	Beta 2 adrenoceptor antagonists for treating orthostatic hypotension
NZ730250A (en)	2014-09-26	2018-03-23	Astrazeneca Ab	1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds and use as sgrm modulators
WO2016124722A1 (en) *	2015-02-06	2016-08-11	Astrazeneca Ab	A process for the preparation of 3-5-{[(1r,2s)-2-[(2,2-difluoropropanyl)amino]-1 -(2,3-dihydro-1,4-benzodioxin-6-yl]propyl]oxy}-1h-indazol-1-yl)-n-[(3r)-tetrahydrofuran-3-yl] benzamide
GB201511382D0 (en)	2015-06-29	2015-08-12	Imp Innovations Ltd	Novel compounds and their use in therapy
EP3350175B1 (en) *	2015-09-15	2019-11-06	Leo Pharma A/S	Non-steroidal glucocorticoid receptor modulators for local drug delivery
WO2017161518A1 (en) *	2016-03-23	2017-09-28	Astrazeneca Ab	New physical form
JP6691972B2 (ja)	2016-03-24	2020-05-13	アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａＡｋｔｉｅｂｏｌａｇ	結晶形態
CN106083837B (zh) *	2016-05-27	2018-08-31	浙江普洛得邦制药有限公司	一种噁唑烷酮类抗菌药物及其中间体的制备方法
TW201927769A (zh)	2017-12-18	2019-07-16	德商歌林達有限公司	經取代之吡咯啶醯胺ｉｉ
US10626106B2 (en)	2017-12-18	2020-04-21	Gruenenthal Gmbh	Substituted pyrrolidine amides I
AU2020207591A1 (en) *	2019-01-11	2021-09-02	Grünenthal GmbH	Substituted pyrrolidine amidesIII
EP3986885B1 (en)	2019-06-19	2023-05-03	Grünenthal GmbH	Substituted pyrrolidine amides iv
EP3986886A2 (en)	2019-06-19	2022-04-27	Grünenthal GmbH	Substituted pyrrolidine amides v
US20230167068A1 (en) *	2019-12-31	2023-06-01	Medshine Discovery Inc.	Benzopyrazole compound
WO2022008705A1 (en)	2020-07-09	2022-01-13	Grünenthal GmbH	Substituted pyrrolidine amines and amides as mediator of the glucocortoid receptor
CN117616020A (zh) *	2021-06-28	2024-02-27	南京明德新药研发有限公司	一种三唑并吡啶取代的吲唑类化合物的晶型及其制备方法
KR102571432B1 (ko) *	2023-02-08	2023-08-29	주식회사 에스씨엘테라퓨틱스	인다졸릴에스테르 및 아미드 유도체를 포함하는 암 치료용 조성물

Family Cites Families (81)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB607840A (en)	1946-02-12	1948-09-06	Bristol Aeroplane Co Ltd	Improvements in or relating to means for feeding ammunition to automatic fire arms
US3992441A (en) *	1972-12-26	1976-11-16	Pfizer Inc.	Sulfamylbenzoic acids
DE3000377A1 (de)	1980-01-07	1981-07-09	Boehringer Mannheim Gmbh, 6800 Mannheim	Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3514696A1 (de)	1985-04-24	1986-11-06	Bayer Ag, 5090 Leverkusen	N-indolylethyl-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung
DE3535167A1 (de)	1985-10-02	1987-04-09	Boehringer Mannheim Gmbh	Neue sulfonyl-phenyl(alkyl)amine, verfahren zu ihrer herstellung sowie arzneimittel
DE3632329A1 (de)	1986-09-24	1988-03-31	Bayer Ag	Substituierte phenylsulfonamide
TW224462B (sl)	1992-02-24	1994-06-01	Squibb & Sons Inc
NZ247440A (en)	1992-05-06	1995-04-27	Squibb & Sons Inc	Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof
CA2114981A1 (en)	1993-02-09	1994-08-10	Kazumi Ogata	Quinolonecarboxylic acid derivatives
DE4323916A1 (de)	1993-07-16	1995-01-19	Basf Ag	Substituierte 2-Phenylpyridine
ATE225334T1 (de)	1993-07-26	2002-10-15	Eisai Co Ltd	Sulfonamide und sulfonsäure-ester mit je einem trizyclischen heteroring
JPH09505375A (ja)	1993-08-30	1997-05-27	エアフローリサーチマニュファクチュアリングコーポレーション	帯付き軸流ファンと共に使用するための再循環制御を伴うハウジング
GB9504854D0 (en) *	1994-03-31	1995-04-26	Zeneca Ltd	Nitrogen derivatives
US5545669A (en)	1994-06-02	1996-08-13	Adams; Jerry L.	Anti-inflammatory compounds
GB9417532D0 (en)	1994-08-31	1994-10-19	Zeneca Ltd	Aromatic compounds
WO1996036595A1 (en)	1995-05-19	1996-11-21	Chiroscience Limited	3,4-disubstituted-phenylsulphonamides and their therapeutic use
TW523506B (en)	1996-12-18	2003-03-11	Ono Pharmaceutical Co	Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients
TW542822B (en)	1997-01-17	2003-07-21	Ajinomoto Kk	Benzamidine derivatives
US6372779B1 (en)	1997-12-29	2002-04-16	Ortho Pharmaceutical Corporation	Anti-inflammatory compounds
ES2317688T3 (es)	1998-01-29	2009-04-16	Amgen Inc.	Moduladores ppar-gamma.
DE19856475A1 (de)	1998-11-27	2000-05-31	Schering Ag	Nichtsteroidale Entzündungshemmer
CA2372715A1 (en)	1999-05-13	2001-04-12	Shionogi & Co., Ltd.	Preventive or therapeutic drugs for diabetes
US6569885B1 (en)	1999-12-23	2003-05-27	Icos Corporation	Cyclic AMP-specific phosphodiesterase inhibitors
JP3957291B2 (ja)	2000-09-11	2007-08-15	ファイザー・プロダクツ・インク	レゾルシノール誘導体
FR2815030A1 (fr)	2000-10-05	2002-04-12	Lipha	Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant et leur utilisation pour la preparation de medicaments
US6838074B2 (en) *	2001-08-08	2005-01-04	Bristol-Myers Squibb Company	Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
WO2003028641A2 (en)	2001-10-01	2003-04-10	Taisho Pharmaceutical Co., Ltd.	Mch receptor antagonists
PL370636A1 (en)	2001-11-22	2005-05-30	Ono Pharmaceultical Co, Ltd.	Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
KR20040094672A (ko)	2002-03-13	2004-11-10	얀센 파마슈티카 엔.브이.	히스톤 디아세틸라제의 신규한 저해제로서의설포닐아미노-유도체
EP1496892B1 (en)	2002-04-11	2011-01-26	Merck Sharp & Dohme Corp.	1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators
US7238717B2 (en)	2002-05-24	2007-07-03	Millennium Pharmaceuticals, Inc.	CCR9 inhibitors and methods of use thereof
JP2004059116A (ja)	2002-07-31	2004-02-26	Sharp Corp	ディスプレイ用基板収納用トレイ及びディスプレイ用基板の取り出し機構並びにディスプレイ用基板の取り出し方法
US20050113450A1 (en)	2002-08-23	2005-05-26	Atli Thorarensen	Antibacterial agents
ES2349164T3 (es)	2002-08-29	2010-12-28	Boehringer Ingelheim Pharmaceuticals Inc.	Derivados de 3-(sulfonamidoetil)-indol para uso como compuestos miméticos de glucocorticoides en el tratamiento de enfermedades inflamatorias, alérgicas y proliferativas.
US6894061B2 (en)	2002-12-04	2005-05-17	Wyeth	Substituted dihydrophenanthridinesulfonamides
US7319111B2 (en)	2003-02-20	2008-01-15	Encysive Pharmaceuticals, Inc.	Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists
GB0308466D0 (en)	2003-04-11	2003-05-21	Novartis Ag	Organic compounds
US20040235892A1 (en)	2003-05-22	2004-11-25	Yujia Dai	Indazole and benzisoxazole kinase inhibitors
US7297709B2 (en)	2003-05-22	2007-11-20	Abbott Laboratories	Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
EP1635800A2 (en)	2003-06-10	2006-03-22	Kalypsys, Inc.	Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
WO2005004810A2 (en)	2003-07-02	2005-01-20	Merck & Co., Inc.	Arylsulfonamide derivatives
AP2006003633A0 (en)	2003-12-19	2006-06-30	Pfizer	Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-BETA-hydroxysteroid dehydrogenase type 1 (11-BETA-HSD-1) for the treatment of diabetes and obesity
JP2005263787A (ja)	2004-02-17	2005-09-29	Ishihara Sangyo Kaisha Ltd	アミド系化合物又はその塩、並びにそれらを含有するサイトカイン産生抑制剤
US20050250820A1 (en)	2004-03-08	2005-11-10	Amgen Inc.	Therapeutic modulation of PPARgamma activity
DE102004028862A1 (de)	2004-06-15	2005-12-29	Merck Patent Gmbh	3-Aminoindazole
SE0402635D0 (sv)	2004-10-29	2004-10-29	Astrazeneca Ab	Chemical compounds
CA2584413A1 (en)	2004-10-29	2006-05-04	Astrazeneca Ab	Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
SE0402636D0 (sv) *	2004-10-29	2004-10-29	Astrazeneca Ab	Chemical compounds
EP1869003B1 (en)	2005-04-14	2013-05-15	Glaxo Group Limited	Indazoles as glucocorticoid receptor ligands
RU2007148225A (ru)	2005-06-10	2009-07-20	БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE)	Глюкокортикоидные миметики, способы их получения, фармацевтические композиции и их применение
US7888381B2 (en)	2005-06-14	2011-02-15	Bristol-Myers Squibb Company	Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity, and use thereof
TW200815361A (en)	2005-10-20	2008-04-01	Astrazeneca Ab	Chemical compounds
GB0522880D0 (en)	2005-11-09	2005-12-21	Glaxo Group Ltd	Novel compounds
US20090170898A1 (en)	2006-03-31	2009-07-02	Malena Bengtsson	Sulphonamide Derivatives as Modulators of the Glucocorticoid Receptor
GB0607840D0 (en)	2006-04-20	2006-05-31	Glaxo Group Ltd	Novel compounds
EA200801997A1 (ru)	2006-04-20	2009-04-28	Глаксо Груп Лимитед	Новые соединения
AU2007272504B2 (en)	2006-07-14	2012-06-28	Eli Lilly And Company	Glucocorticoid receptor modulator and methods of use
GB0620385D0 (en)	2006-10-13	2006-11-22	Glaxo Group Ltd	Novel compounds
GB0620406D0 (en)	2006-10-13	2006-11-22	Glaxo Group Ltd	Novel compounds
US8119681B2 (en)	2006-10-23	2012-02-21	Merck Sharp & Dohme Corp.	2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydrocyclopenta [ƒ]indazole-5-YL]ethyl phenyl derivatives as glucocorticoid receptor ligands
EP2094692B1 (en)	2006-11-01	2012-11-28	Bristol-Myers Squibb Company	Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof
JP2010508358A (ja)	2006-11-01	2010-03-18	ブリストル−マイヤーズスクイブカンパニー	グルココルチコイド受容体、ＡＰ−１、および／またはＮＦ−κＢ活性の調節剤、並びにその使用
TW200829578A (en)	2006-11-23	2008-07-16	Astrazeneca Ab	Chemical compounds 537
US20120065173A1 (en)	2006-11-23	2012-03-15	Markus Berger	Chemical compounds
WO2008070507A2 (en)	2006-12-06	2008-06-12	Boehringer Ingelheim International Gmbh	Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
JO2754B1 (en)	2006-12-21	2014-03-15	استرازينكا ايه بي	Amylendazoleil derivatives for the treatment of glucocorticoid-mediated disorders
WO2008079073A1 (en)	2006-12-22	2008-07-03	Astrazeneca Ab	Indazolyl sulphonamide derivatives for the treatment of glucocorticoid receptor mediated disorders
WO2008124745A1 (en)	2007-04-10	2008-10-16	Boehringer Ingelheim International Gmbh	Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US20100063282A1 (en)	2007-04-10	2010-03-11	Boehringer Ingelheim International Gmbh	Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions, and Uses Thereof
GB0708858D0 (en)	2007-05-08	2007-06-13	Glaxo Group Ltd	Novel compounds
DE102007029419A1 (de)	2007-06-26	2009-01-02	Emsland-Stärke GmbH	Filamentfaserschlichtemittel und Verwendung desselben
GB0720544D0 (en)	2007-10-19	2007-11-28	Glaxo Group Ltd	Novel compounds
GB0720557D0 (en)	2007-10-19	2007-11-28	Glaxo Group Ltd	Novel compounds
GB0720549D0 (en)	2007-10-19	2007-11-28	Glaxo Group Ltd	Novel compounds
GB0720546D0 (en)	2007-10-19	2007-11-28	Glaxo Group Ltd	Novel compounds
GB0720556D0 (en)	2007-10-19	2007-11-28	Glaxo Group Ltd	Novel compounds
GB0722211D0 (en)	2007-11-12	2007-12-27	Glaxo Group Ltd	Novel compounds
GB0724254D0 (en)	2007-12-12	2008-01-23	Glaxo Group Ltd	Novel compounds
WO2009108525A2 (en)	2008-02-26	2009-09-03	Merck & Co., Inc.	Hexahydrocyclopentyl[f]indazole carboxamides and derivatives thereof as selective glucocorticoid receptor modulators
JP2011513409A (ja)	2008-03-06	2011-04-28	メルク・シャープ・エンド・ドーム・コーポレイション	選択的グルココルチコイドレセプターモジュレーターとしてのヘキサヒドロシクロペンチル［ｆ］インダゾールスルホンアミドおよびこれらの誘導体
SA109300309B1 (ar) *	2008-05-20	2013-01-22	باير شيرنج فارما ايه جي	مشتقات فينيل وبنزو داي أوكسينيل إندازول بها استبدال

2009
- 2009-05-19 SA SA109300309A patent/SA109300309B1/ar unknown
- 2009-05-19 TW TW098116533A patent/TWI445705B/zh active
- 2009-05-19 UY UY0001031831A patent/UY31831A/es not_active Application Discontinuation
- 2009-05-19 TW TW098116534A patent/TW200951114A/zh unknown
- 2009-05-19 UY UY0001031832A patent/UY31832A/es not_active Application Discontinuation
- 2009-05-19 US US12/468,561 patent/US8211930B2/en not_active Expired - Fee Related
- 2009-05-19 US US12/468,494 patent/US20100080786A1/en not_active Abandoned
- 2009-05-20 ME MEP-2016-24A patent/ME02455B/me unknown
- 2009-05-20 EP EP09750864A patent/EP2291359A4/en not_active Withdrawn
- 2009-05-20 EP EP09750866.7A patent/EP2291369B1/en active Active
- 2009-05-20 MX MX2010012529A patent/MX2010012529A/es active IP Right Grant
- 2009-05-20 PT PT97508667T patent/PT2291369E/pt unknown
- 2009-05-20 AU AU2009249872A patent/AU2009249872A1/en not_active Abandoned
- 2009-05-20 UA UAA201013070A patent/UA102543C2/uk unknown
- 2009-05-20 CN CN200980128407XA patent/CN102112449A/zh active Pending
- 2009-05-20 SI SI200931365T patent/SI2291369T1/sl unknown
- 2009-05-20 EP EP13165585.4A patent/EP2620435A1/en not_active Withdrawn
- 2009-05-20 JP JP2011510458A patent/JP2011520954A/ja active Pending
- 2009-05-20 PE PE2009000705A patent/PE20091925A1/es active IP Right Grant
- 2009-05-20 PE PE2009000706A patent/PE20091974A1/es not_active Application Discontinuation
- 2009-05-20 DK DK09750866.7T patent/DK2291369T3/en active
- 2009-05-20 MX MX2010012390A patent/MX2010012390A/es not_active Application Discontinuation
- 2009-05-20 WO PCT/SE2009/000267 patent/WO2009142571A1/en active Application Filing
- 2009-05-20 PA PA20098827001A patent/PA8827001A1/es unknown
- 2009-05-20 KR KR1020107025957A patent/KR101593253B1/ko active IP Right Grant
- 2009-05-20 CL CL2009001248A patent/CL2009001248A1/es unknown
- 2009-05-20 WO PCT/SE2009/000265 patent/WO2009142569A1/en active Application Filing
- 2009-05-20 ES ES09750866.7T patent/ES2561598T3/es active Active
- 2009-05-20 CA CA2724508A patent/CA2724508C/en active Active
- 2009-05-20 AR ARP090101815A patent/AR071857A1/es active IP Right Grant
- 2009-05-20 MY MYPI2010005417A patent/MY173448A/en unknown
- 2009-05-20 HU HUE09750866A patent/HUE027217T2/en unknown
- 2009-05-20 CA CA2724584A patent/CA2724584A1/en not_active Abandoned
- 2009-05-20 RS RS20160050A patent/RS54700B1/en unknown
- 2009-05-20 AR ARP090101814A patent/AR071856A1/es unknown
- 2009-05-20 PL PL09750866T patent/PL2291369T3/pl unknown
- 2009-05-20 NZ NZ588994A patent/NZ588994A/xx unknown
- 2009-05-20 CL CL2009001247A patent/CL2009001247A1/es unknown
- 2009-05-20 AU AU2009249874A patent/AU2009249874B2/en active Active
- 2009-05-20 JP JP2011510459A patent/JP5579704B2/ja active Active
- 2009-05-20 PA PA20098827101A patent/PA8827101A1/es unknown
- 2009-05-20 KR KR1020107025956A patent/KR20110007208A/ko not_active Application Discontinuation
- 2009-05-20 BR BRPI0912878-6A patent/BRPI0912878B1/pt active IP Right Grant
- 2009-05-20 EA EA201001682A patent/EA018629B8/ru not_active IP Right Cessation
- 2009-05-20 BR BRPI0912855A patent/BRPI0912855A2/pt not_active IP Right Cessation
- 2009-05-20 CN CN200980128406.5A patent/CN102099355B/zh active Active
- 2009-05-20 EA EA201001683A patent/EA201001683A1/ru unknown
2010
- 2010-11-04 IL IL209122A patent/IL209122A0/en unknown
- 2010-11-04 CO CO10137238A patent/CO6331310A2/es active IP Right Grant
- 2010-11-04 ZA ZA2010/07919A patent/ZA201007919B/en unknown
- 2010-11-04 IL IL209121A patent/IL209121A/en active IP Right Grant
- 2010-11-04 ZA ZA2010/07918A patent/ZA201007918B/en unknown
- 2010-11-04 CO CO10137241A patent/CO6351783A2/es not_active Application Discontinuation
- 2010-11-19 DO DO2010000359A patent/DOP2010000359A/es unknown
- 2010-11-19 EC EC2010010620A patent/ECSP10010620A/es unknown
- 2010-11-19 SV SV2010003737A patent/SV2010003737A/es unknown
- 2010-11-19 DO DO2010000357A patent/DOP2010000357A/es unknown
- 2010-11-19 SV SV2010003738A patent/SV2010003738A/es not_active Application Discontinuation
- 2010-11-19 CR CR11801A patent/CR11801A/es unknown
- 2010-11-19 CR CR11802A patent/CR11802A/es not_active Application Discontinuation
- 2010-11-19 HN HN2010002478A patent/HN2010002478A/es unknown
- 2010-11-19 NI NI201000199A patent/NI201000199A/es unknown
- 2010-11-19 EC EC2010010619A patent/ECSP10010619A/es unknown
- 2010-12-06 MA MA33399A patent/MA32383B1/fr unknown
- 2010-12-06 MA MA33398A patent/MA32382B1/fr unknown
2011
- 2011-08-22 HK HK11108823.3A patent/HK1154580A1/zh unknown
2012
- 2012-06-06 US US13/490,204 patent/US8916600B2/en active Active
2014
- 2014-07-09 JP JP2014141429A patent/JP2014185188A/ja active Pending
- 2014-11-19 US US14/547,809 patent/US9512110B2/en active Active
2016
- 2016-01-22 HR HRP20160071TT patent/HRP20160071T1/hr unknown
- 2016-02-03 CY CY20161100092T patent/CY1117330T1/el unknown
- 2016-12-02 US US15/367,936 patent/US9738632B2/en active Active

Also Published As

Publication number	Publication date
WO2009142571A1 (en)	2009-11-26
US20170081315A1 (en)	2017-03-23
ECSP10010620A (es)	2010-12-30
SA109300309B1 (ar)	2013-01-22
EP2291369B1 (en)	2015-11-04
ECSP10010619A (es)	2010-12-30
TW200951128A (en)	2009-12-16
AU2009249874A1 (en)	2009-11-26
BRPI0912878A2 (pt)	2020-08-18
JP2014185188A (ja)	2014-10-02
PE20091925A1 (es)	2010-01-24
CA2724508C (en)	2016-10-25
US8916600B2 (en)	2014-12-23
UY31832A (es)	2010-01-05
CN102112449A (zh)	2011-06-29
ME02455B (me)	2017-02-20
DOP2010000357A (es)	2010-12-15
BRPI0912878B1 (pt)	2021-11-03
HN2010002478A (es)	2013-01-15
EA018629B1 (ru)	2013-09-30
AU2009249872A1 (en)	2009-11-26
KR101593253B1 (ko)	2016-02-11
NI201000199A (es)	2012-11-07
CO6351783A2 (es)	2011-12-20
DOP2010000359A (es)	2010-12-15
MX2010012529A (es)	2011-03-29
IL209121A (en)	2015-05-31
TW200951114A (en)	2009-12-16
UY31831A (es)	2010-01-05
PL2291369T3 (pl)	2016-04-29
US9512110B2 (en)	2016-12-06
EP2291359A1 (en)	2011-03-09
WO2009142569A1 (en)	2009-11-26
KR20110007208A (ko)	2011-01-21
PT2291369E (pt)	2016-03-11
US9738632B2 (en)	2017-08-22
RS54700B1 (en)	2016-08-31
SV2010003737A (es)	2011-03-15
CN102099355A (zh)	2011-06-15
MY173448A (en)	2020-01-25
MA32383B1 (fr)	2011-06-01
CY1117330T1 (el)	2017-04-26
SV2010003738A (es)	2011-03-15
AR071857A1 (es)	2010-07-21
EA201001683A1 (ru)	2011-06-30
US8211930B2 (en)	2012-07-03
EP2291359A4 (en)	2011-05-11
TWI445705B (zh)	2014-07-21
ES2561598T3 (es)	2016-02-29
CL2009001248A1 (es)	2010-06-11
CR11801A (es)	2011-02-15
JP2011520954A (ja)	2011-07-21
CN102099355B (zh)	2014-11-05
ZA201007918B (en)	2011-07-27
HRP20160071T1 (hr)	2016-02-26
BRPI0912855A2 (pt)	2015-10-13
CO6331310A2 (es)	2011-10-20
IL209121A0 (en)	2011-01-31
AR071856A1 (es)	2010-07-21
EP2291369A4 (en)	2011-05-11
US20100080786A1 (en)	2010-04-01
MX2010012390A (es)	2011-03-03
WO2009142571A8 (en)	2011-02-03
EP2620435A1 (en)	2013-07-31
PA8827101A1 (es)	2009-12-16
DK2291369T3 (en)	2016-02-01
PA8827001A1 (es)	2009-12-16
US20100087489A1 (en)	2010-04-08
UA102543C2 (uk)	2013-07-25
HK1154580A1 (zh)	2012-06-29
US20120302617A1 (en)	2012-11-29
PE20091974A1 (es)	2010-02-05
CA2724508A1 (en)	2009-11-26
JP2011520955A (ja)	2011-07-21
MA32382B1 (fr)	2011-06-01
CA2724584A1 (en)	2009-11-26
KR20110036699A (ko)	2011-04-08
CR11802A (es)	2011-01-12
IL209122A0 (en)	2011-01-31
JP5579704B2 (ja)	2014-08-27
EA201001682A1 (ru)	2011-06-30
CL2009001247A1 (es)	2010-07-23
US20150080434A1 (en)	2015-03-19
NZ588994A (en)	2012-08-31
EA018629B8 (ru)	2013-12-30
ZA201007919B (en)	2011-07-27
EP2291369A1 (en)	2011-03-09
AU2009249874B2 (en)	2012-08-16
HUE027217T2 (en)	2016-08-29

Publication	Publication Date	Title
HK1154580A1 (zh)	2012-06-29	苯並二氧雜環己烯基取代的吲唑衍生物
HK1256310A1 (zh)	2019-09-20	N-磺酰基吡咯衍生物
EP2194045A4 (en)	2011-09-21	SUBSTITUTED PYRAZOLE DERIVATIVE
IL210548A0 (en)	2011-03-31	Spiroaminodihydrothiazine derivatives
EP2376494A4 (en)	2012-07-11	DIHYDROPYRIMIDOPIRYMIDINE DERIVATIVES
PL2308877T3 (pl)	2014-07-31	Pochodne imidazopirydyn-2-onu
IL199627A0 (en)	2010-04-15	5-pyridinone substituted indazoles
EP2331543A4 (en)	2013-06-19	3-DÉSAZANEPLANOCINE DERIVATIVES
ZA201105440B (en)	2012-03-28	Pyridazinone derivatives
IL212636A0 (en)	2011-07-31	Pyridazinone derivatives
IL210406A0 (en)	2011-03-31	Pyrrolopyridinylpyrimidin - 2 - ylamine derivatives
IL202034A0 (en)	2010-06-16	Heterocyclic indazole derivatives
EP2291078A4 (en)	2011-08-24	OXAZOLBENZIMIDAZOLDERIVATE
EP2279532A4 (en)	2011-07-27	OXAZOLBENZIMIDAZOLDERIVATE
IL207225A0 (en)	2010-12-30	Indazole derivatives
IL210869A0 (en)	2011-04-28	Imidazothiadiazoles derivatives
ZA201008330B (en)	2011-09-28	Pyridazinone derivatives
ZA201005382B (en)	2011-10-26	Substituted heteroarylamide diazepinopyrimidone derivatives
IL199628A0 (en)	2010-04-15	5-furopyridinone substituted indazoles
IL210164A0 (en)	2011-03-31	Thiazolylpiperidine derivatives
ZA201005381B (en)	2011-10-26	Substituted heteroarylamide oxazepinopyrimidone derivatives
IL213424A0 (en)	2011-07-31	Quinazolinamide derivatives
IL208548A0 (en)	2010-12-30	2-phenyl-4-cyclopropyl-pyrimidine derivatives
EP2373313A4 (en)	2012-06-13	SUBSTITUTED PYRAZOL COMPOUNDS
EP2292613A4 (en)	2012-05-09	DIHYDROINDOLINONDERIVATE